| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
501 |
| issn |
1743-4297
1743-4300 |
| issueIdentifier |
10 |
| pageRange |
500-501 |
| publicationName |
Nature clinical practice. Cardiovascular medicine |
| startingPage |
500 |
| bibliographicCitation |
Valettas N. Does clopidogrel provide additional benefit to aspirin and fibrinolytic therapy in patients after STEMI? Nature Clinical Practice Cardiovascular Medicine. 2005 Oct;2(10):500–1. doi: 10.1038/ncpcardio0293. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9acc9ed9bf7f7b894f287f5843e59f74 |
| date |
200510 |
| identifier |
https://doi.org/10.1038/ncpcardio0293
https://pubmed.ncbi.nlm.nih.gov/16186842 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32523
https://portal.issn.org/resource/ISSN/1743-4300
https://portal.issn.org/resource/ISSN/1743-4297 |
| language |
English |
| source |
https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Does clopidogrel provide additional benefit to aspirin and fibrinolytic therapy in patients after STEMI? |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6592 |